LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Gauffre, Pierre"
  2. AU="Melvin, Jennifer E"

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: A second type of N7-guanine RNA cap methyltransferase in an unusual locus of a large RNA virus genome.

    Shannon, Ashleigh / Sama, Bhawna / Gauffre, Pierre / Guez, Théo / Debart, Françoise / Vasseur, Jean-Jacques / Decroly, Etienne / Canard, Bruno / Ferron, François

    Nucleic acids research

    2022  Volume 50, Issue 19, Page(s) 11186–11198

    Abstract: The order Nidovirales is a diverse group of (+)RNA viruses, with a common genome organization and conserved set of replicative and editing enzymes. In particular, RNA methyltransferases play a central role in mRNA stability and immune escape. However, ... ...

    Abstract The order Nidovirales is a diverse group of (+)RNA viruses, with a common genome organization and conserved set of replicative and editing enzymes. In particular, RNA methyltransferases play a central role in mRNA stability and immune escape. However, their presence and distribution in different Nidovirales families is not homogeneous. In Coronaviridae, the best characterized family, two distinct methytransferases perform methylation of the N7-guanine and 2'-OH of the RNA-cap to generate a cap-1 structure (m7GpppNm). The genes of both of these enzymes are located in the ORF1b genomic region. While 2'-O-MTases can be identified for most other families based on conservation of both sequence motifs and genetic loci, identification of the N7-guanine methyltransferase has proved more challenging. Recently, we identified a putative N7-MTase domain in the ORF1a region (N7-MT-1a) of certain members of the large genome Tobaniviridae family. Here, we demonstrate that this domain indeed harbors N7-specific methyltransferase activity. We present its structure as the first N7-specific Rossmann-fold (RF) MTase identified for (+)RNA viruses, making it remarkably different from that of the known Coronaviridae ORF1b N7-MTase gene. We discuss the evolutionary implications of such an appearance in this unexpected location in the genome, which introduces a split-off in the classification of Tobaniviridae.
    MeSH term(s) Humans ; RNA Caps/genetics ; Methyltransferases/genetics ; Methyltransferases/chemistry ; Guanine ; Nidovirales ; Genome, Viral ; RNA, Viral/genetics
    Chemical Substances RNA Caps ; Methyltransferases (EC 2.1.1.-) ; Guanine (5Z93L87A1R) ; RNA, Viral
    Language English
    Publishing date 2022-10-17
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 186809-3
    ISSN 1362-4962 ; 1362-4954 ; 0301-5610 ; 0305-1048
    ISSN (online) 1362-4962 ; 1362-4954
    ISSN 0301-5610 ; 0305-1048
    DOI 10.1093/nar/gkac876
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: AT-752 targets multiple sites and activities on the Dengue virus replication enzyme NS5.

    Feracci, Mikael / Eydoux, Cécilia / Fattorini, Véronique / Lo Bello, Lea / Gauffre, Pierre / Selisko, Barbara / Sutto-Ortiz, Priscila / Shannon, Ashleigh / Xia, Hongjie / Shi, Pei-Yong / Noel, Mathieu / Debart, Françoise / Vasseur, Jean-Jacques / Good, Steve / Lin, Kai / Moussa, Adel / Sommadossi, Jean-Pierre / Chazot, Aurélie / Alvarez, Karine /
    Guillemot, Jean-Claude / Decroly, Etienne / Ferron, François / Canard, Bruno

    Antiviral research

    2023  Volume 212, Page(s) 105574

    Abstract: AT-752 is a guanosine analogue prodrug active against dengue virus (DENV). In infected cells, it is metabolized into 2'-methyl-2'-fluoro guanosine 5'-triphosphate (AT-9010) which inhibits RNA synthesis in acting as a RNA chain terminator. Here we show ... ...

    Abstract AT-752 is a guanosine analogue prodrug active against dengue virus (DENV). In infected cells, it is metabolized into 2'-methyl-2'-fluoro guanosine 5'-triphosphate (AT-9010) which inhibits RNA synthesis in acting as a RNA chain terminator. Here we show that AT-9010 has several modes of action on DENV full-length NS5. AT-9010 does not inhibit the primer pppApG synthesis step significantly. However, AT-9010 targets two NS5-associated enzyme activities, the RNA 2'-O-MTase and the RNA-dependent RNA polymerase (RdRp) at its RNA elongation step. Crystal structure and RNA methyltransferase (MTase) activities of the DENV 2 MTase domain in complex with AT-9010 at 1.97 Å resolution shows the latter bound to the GTP/RNA-cap binding site, accounting for the observed inhibition of 2'-O but not N7-methylation activity. AT-9010 is discriminated ∼10 to 14-fold against GTP at the NS5 active site of all four DENV1-4 NS5 RdRps, arguing for significant inhibition through viral RNA synthesis termination. In Huh-7 cells, DENV1-4 are equally sensitive to AT-281, the free base of AT-752 (EC
    MeSH term(s) Humans ; Dengue/drug therapy ; Dengue Virus/physiology ; Guanosine/pharmacology ; Guanosine/metabolism ; Guanosine Triphosphate/metabolism ; RNA, Viral/metabolism ; Viral Nonstructural Proteins/genetics ; Virus Replication
    Chemical Substances Guanosine (12133JR80S) ; Guanosine Triphosphate (86-01-1) ; RNA, Viral ; Viral Nonstructural Proteins ; AT-752
    Language English
    Publishing date 2023-03-09
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 306628-9
    ISSN 1872-9096 ; 0166-3542
    ISSN (online) 1872-9096
    ISSN 0166-3542
    DOI 10.1016/j.antiviral.2023.105574
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase.

    Shannon, Ashleigh / Fattorini, Véronique / Sama, Bhawna / Selisko, Barbara / Feracci, Mikael / Falcou, Camille / Gauffre, Pierre / El Kazzi, Priscila / Delpal, Adrien / Decroly, Etienne / Alvarez, Karine / Eydoux, Cécilia / Guillemot, Jean-Claude / Moussa, Adel / Good, Steven S / La Colla, Paolo / Lin, Kai / Sommadossi, Jean-Pierre / Zhu, Yingxiao /
    Yan, Xiaodong / Shi, Hui / Ferron, François / Canard, Bruno

    Nature communications

    2022  Volume 13, Issue 1, Page(s) 621

    Abstract: The guanosine analog AT-527 represents a promising candidate against Severe Acute Respiratory Syndrome coronavirus type 2 (SARS-CoV-2). AT-527 recently entered phase III clinical trials for the treatment of COVID-19. Once in cells, AT-527 is converted ... ...

    Abstract The guanosine analog AT-527 represents a promising candidate against Severe Acute Respiratory Syndrome coronavirus type 2 (SARS-CoV-2). AT-527 recently entered phase III clinical trials for the treatment of COVID-19. Once in cells, AT-527 is converted into its triphosphate form, AT-9010, that presumably targets the viral RNA-dependent RNA polymerase (RdRp, nsp12), for incorporation into viral RNA. Here we report a 2.98 Å cryo-EM structure of the SARS-CoV-2 nsp12-nsp7-nsp8
    MeSH term(s) Antiviral Agents/chemistry ; Antiviral Agents/pharmacology ; COVID-19/virology ; Cryoelectron Microscopy ; Enzyme Inhibitors/chemistry ; Enzyme Inhibitors/pharmacology ; Guanosine Monophosphate/analogs & derivatives ; Guanosine Monophosphate/chemistry ; Guanosine Monophosphate/pharmacology ; Humans ; Phosphoramides/chemistry ; Phosphoramides/pharmacology ; RNA-Dependent RNA Polymerase/antagonists & inhibitors ; RNA-Dependent RNA Polymerase/chemistry ; RNA-Dependent RNA Polymerase/genetics ; RNA-Dependent RNA Polymerase/metabolism ; SARS-CoV-2/chemistry ; SARS-CoV-2/drug effects ; SARS-CoV-2/enzymology ; SARS-CoV-2/genetics ; Viral Proteins/antagonists & inhibitors ; Viral Proteins/genetics ; Viral Proteins/metabolism
    Chemical Substances AT-511 ; Antiviral Agents ; Enzyme Inhibitors ; Phosphoramides ; Viral Proteins ; Guanosine Monophosphate (85-32-5) ; RNA-Dependent RNA Polymerase (EC 2.7.7.48)
    Language English
    Publishing date 2022-02-02
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-022-28113-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Protein-primed RNA synthesis in SARS-CoVs and structural basis for inhibition by AT-527

    Shannon, Ashleigh / Fattorini, Veronique / Sama, Bhawna / Selisko, Barbara / Feracci, Mikael / Falcou, Camille / Gauffre, Pierre / El Kazzi, Priscila / Decroly, Etienne / Rabah, Nadia / Toulon, Karine / Eydoux, Cecilia / Guillemot, Jean-Claude / Noel, Mathieu / Debart, Francoise / Vasseur, Jean-Jacques / Moussa, Adel / Good, Steven / Lin, Kai /
    Sommadossi, Jean-Pierre / Zhu, Yingxiao / Yan, Xiaodong / Shi, Hui / Ferron, Francois / Canard, Bruno

    bioRxiv

    Abstract: How viruses from the Coronaviridae family initiate viral RNA synthesis is unknown. Here we show that the SARS-CoV-1 and -2 Nidovirus RdRp-Associated Nucleotidyltransferase (NiRAN) domain on nsp12 uridylates the viral cofactor nsp8, forming a UMP-Nsp8 ... ...

    Abstract How viruses from the Coronaviridae family initiate viral RNA synthesis is unknown. Here we show that the SARS-CoV-1 and -2 Nidovirus RdRp-Associated Nucleotidyltransferase (NiRAN) domain on nsp12 uridylates the viral cofactor nsp8, forming a UMP-Nsp8 covalent intermediate that subsequently primes RNA synthesis from a poly(A) template; a protein-priming mechanism reminiscent of Picornaviridae enzymes. In parallel, the RdRp active site of nsp12 synthesizes a pppGpU primer, which primes (-)ssRNA synthesis at the precise genome-poly(A) junction. The guanosine analogue 59-triphosphate AT-9010 (prodrug: AT-527) tightly binds to the NiRAN and inhibits both nsp8-labeling and the initiation of RNA synthesis. A 2.98 A resolution Cryo-EM structure of the SARS-CoV-2 nsp12-nsp7-(nsp8)2 /RNA/NTP quaternary complex shows AT-9010 simultaneously binds to both NiRAN and RdRp active site of nsp12, blocking their respective activities. AT-527 is currently in phase II clinical trials, and is a potent inhibitor of SARS-CoV-1 and -2, representing a promising drug for COVID-19 treatment.
    Keywords covid19
    Language English
    Publishing date 2021-03-23
    Publisher Cold Spring Harbor Laboratory
    Document type Article ; Online
    DOI 10.1101/2021.03.23.436564
    Database COVID19

    Kategorien

To top